<Disease><Name>CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED</Name><Synonym>CPT2 DEFICIENCY, LATE-ONSET, CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET</Synonym><OMIM><Number>255110</Number><URL>http://omim.org/entry/255110</URL></OMIM><Orphanet><Number>228302</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=228302</URL></Orphanet><Protein><Number>Carnitine palmitoyl transferase II (CPT II), inner mitochondrial membrane</Number><URL>http://www.uniprot.org/uniprot/P23786</URL></Protein><ExPASy><Number>2.3.1.21</Number><URL>http://enzyme.expasy.org/EC/2.3.1.21</URL></ExPASy><Gene>1p32.3</Gene><ICD>E71.3</ICD><Summary>rare (&lt;1:750000);autosomal recessive ;autosomal dominant;mutation in the carnitine palmitoyltransferase II gene;Three phenotypes of CPT II deficiency: ;- lethal neonatal form -&gt; 600649;- severe infantile hepatocardiomuscular form -&gt; 608836;- mild myopathic form (most frequent) -&gt; 255110;Muscle CPT II deficiency is the most frequent type  [Lehmann D&#160; et al. 2017];CPT-1 deficiency can be missed when analysis is performed in plasma, whereas CPT-2 deficiency can be missed when analysis is performed in DBS [;de Sain-van der Velden MG ;2013]</Summary><Symptoms><symtomp><id>3186</id><symptom>brown colored urine</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3679</id><symptom>cardiomyopathy, mixed type / cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2364</id><symptom>intracerebral, cortical or paraventricular cysts</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2147</id><symptom>muscle cramps</symptom><category>MUSCLES</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2029</id><symptom>pain, muscle / myalgia, pain muscle</symptom><category>GENERAL TOPICS | MUSCLES</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3875</id><symptom>polycystic kidneys</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3202</id><symptom>rhabdomyolysis</symptom><category>MUSCLES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1934</id><symptom>sweating</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>3998</id><symptom>urine color, abnormal</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2127</id><name>Myoglobin</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>65.00</max><unit>ng/ml</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>1992</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>19.00</min><max>71.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>9</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>25.00</min><max>80.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1092</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>11.00</min><max>68.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>37</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>45.00</min><max>97.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>278</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>36.00</min><max>110.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>277</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>47.00</min><max>91.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>276</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>41.00</min><max>79.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>275</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>28.00</min><max>56.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>274</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>24.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>273</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>27.00</min><max>59.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>279</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>27.00</min><max>57.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>926</id><name>Carnitine palmitoyltransferase II</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>normal/inc</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>495</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1121</id><name>Dicarboxylic acids</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>traces</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>307</id><name>Lactate dehydrogenase (LDH)</name><specimen>serum</specimen><value>increased</value><min>110.00</min><max>210.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1115</id><name>Lactate dehydrogenase (LDH)</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>330.00</max><unit>U/l</unit><age>&gt; 10years</age><method /><comment /></metabolite><metabolite><id>1259</id><name>Linoleoylcarnitine (C18:2)</name><specimen>blood</specimen><value>increased</value><min>0.06</min><max>0.59</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1260</id><name>Linoleoylcarnitine (C18:2)</name><specimen>serum</specimen><value>increased</value><min>0.10</min><max>1.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1113</id><name>Long chain acyl carnitines</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>82</id><name>Long chain acyl carnitines</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1117</id><name>Long chain acyl carnitines</name><specimen>tissues</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1261</id><name>Oleoylcarnitine (C18:1)</name><specimen>blood</specimen><value>increased</value><min>0.73</min><max>3.15</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1262</id><name>Oleoylcarnitine (C18:1)</name><specimen>serum</specimen><value>increased</value><min>1.24</min><max>5.36</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1253</id><name>Palmitoylcarnitine (C16)</name><specimen>blood</specimen><value>increased</value><min>1.53</min><max>8.63</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1254</id><name>Palmitoylcarnitine (C16)</name><specimen>serum</specimen><value>increased</value><min>2.60</min><max>14.67</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1263</id><name>Stearoylcarnitine (C18)</name><specimen>blood</specimen><value>increased</value><min>0.47</min><max>2.84</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1264</id><name>Stearoylcarnitine (C18)</name><specimen>serum</specimen><value>increased</value><min>0.80</min><max>4.83</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>normal/inc</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>8210</id><title>The etiology of rhabdomyolysis: an interaction between genetic susceptibilities and external triggers</title><author>Kruijt N,</author><journal>Eur J Neurol</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>8211</id><title>Fever, Fasting, and Rhabdomyolysis in an Adult Male</title><author>Shukla SG,</author><journal>Neurol India</journal><year>2020</year><book /><volume>68</volume><number>1</number><pages>182-184</pages><co_aut>Verma A.</co_aut></literature><literature><id>5375</id><title>Carnitine Palmitoyltransferase II Deficiency</title><author>Wieser T</author><journal>GeneReviews&#174; [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>6530</id><title>Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: A questionnaire-based survey</title><author>Joshi PR,</author><journal>J Clin Neurosci</journal><year>2019</year><book /><volume>59</volume><number>0</number><pages>32-36</pages><co_aut>Deschauer M, Zierz S</co_aut></literature><literature><id>7300</id><title>Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency</title><author>Motlagh Scholle L,</author><journal>Int J Mol Sci</journal><year>2019</year><book /><volume>20</volume><number>6</number><pages>E1400</pages><co_aut>et al.</co_aut></literature><literature><id>7301</id><title>Carnitine palmitoyltransferase II deficiency with a focus on newborn screening</title><author>Tajima G,</author><journal>J Hum Genet</journal><year>2019</year><book /><volume>64</volume><number>2</number><pages>87-98</pages><co_aut>Hara K, Yuasa M</co_aut></literature><literature><id>6531</id><title>Acute Respiratory Infection Unveiling CPT II Deficiency</title><author>Blah N,</author><journal>Int J Mol Sci</journal><year>2018</year><book /><volume>19</volume><number>10</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5373</id><title>Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features</title><author>Lehmann D,</author><journal>Int J Mol Sci</journal><year>2017</year><book /><volume>18</volume><number>1</number><pages>E82-</pages><co_aut>et al.</co_aut></literature><literature><id>6532</id><title>Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for a</title><author>Tajima G,</author><journal>Mol Genet Metab</journal><year>2017</year><book /><volume>122</volume><number>3</number><pages>67-75</pages><co_aut>et al.</co_aut></literature><literature><id>6533</id><title>Sudden infant death from neonate carnitine palmitoyl transferase II deficiency</title><author>Du SH,</author><journal>Forensic Sci Int</journal><year>2017</year><book /><volume>278</volume><number>0</number><pages>e41-44</pages><co_aut>et al.</co_aut></literature><literature><id>4492</id><title>Diagnostic pitfall in antenatal manifestations of CPT II deficiency</title><author>Boemer F,</author><journal>Clin Genet</journal><year>2016</year><book /><volume>89</volume><number>2</number><pages>193-197</pages><co_aut>et al.</co_aut></literature><literature><id>3690</id><title>Neonatal Carnitine Palmitoyltransferase II Deficiency: A Lethal Entity</title><author>Malik S,</author><journal>J Clin Diagn Res</journal><year>2015</year><book /><volume>9</volume><number>10</number><pages>SD01-02</pages><co_aut>et al.</co_aut></literature><literature><id>3691</id><title>Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency</title><author>Yasuno T,</author><journal>Biochem Biophys Res Commun</journal><year>2014</year><book /><volume>448</volume><number>2</number><pages>175-181</pages><co_aut>et al.</co_aut></literature><literature><id>3692</id><title>Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency</title><author>Lehmann D,</author><journal>J Neurol Sci</journal><year>2014</year><book /><volume>339</volume><number>1</number><pages>183-188</pages><co_aut>Zierz S</co_aut></literature><literature><id>3693</id><title>Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients</title><author>Joshi PR,</author><journal>J Neurol Sci</journal><year>2014</year><book /><volume>338</volume><number>1</number><pages>107-111</pages><co_aut>Deschauer M2, Zierz S</co_aut></literature><literature><id>3696</id><title>Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure</title><author>Topcu Y,</author><journal>Pediatr Emerg Care</journal><year>2014</year><book /><volume>30</volume><number>5</number><pages>343-344</pages><co_aut>et al.</co_aut></literature><literature><id>3685</id><title>Differences between acylcarnitine profiles in plasma and bloodspots</title><author>de Sain-van der Velden MG,</author><journal>Mol Genet Metab</journal><year>2013</year><book /><volume>110</volume><number>1</number><pages>116-121</pages><co_aut>et al.</co_aut></literature><literature><id>3694</id><title>Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmi</title><author>Isackson PJ,</author><journal>Muscle Nerve</journal><year>2013</year><book /><volume>47</volume><number>2</number><pages>224-229</pages><co_aut>et al.</co_aut></literature><literature><id>3695</id><title>Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency</title><author>Joshi PR,</author><journal>Wien Klin Wochenschr</journal><year>2012</year><book /><volume>124</volume><number>23</number><pages>851-854</pages><co_aut>Deschauer M, Zierz S</co_aut></literature><literature><id>2955</id><title>Labour management of a woman with carnitine palmitoyl transferase type 2 deficiency</title><author>Slater PM</author><journal>Anaesth Intensive Care</journal><year>2009</year><book /><volume>37</volume><number>2</number><pages>305-308</pages><co_aut>Grivell R, Cyna AM</co_aut></literature><literature><id>2956</id><title>SEVERE INFANTILE CARNITINE PALMITOYLTRANSFERASE II (CPT II) DEFICIENCY IN 19-WEEK FETAL SIBS</title><author>Meir K</author><journal>Pediatr Dev Pathol</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2768</id><title>PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.</title><author>Djouadi F</author><journal>J Inherit Metab Dis</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Bastin J</co_aut></literature><literature><id>4135</id><title>Reversible asphyxial status in a newborn due to neonatal form of carnitine palmitoyltransferase II deficiency</title><author>Brucknerova I;</author><journal>Neuro Endocrinol Lett</journal><year>2008</year><book /><volume>29</volume><number>5</number><pages>627-630</pages><co_aut>et al.</co_aut></literature><literature><id>2339</id><title>Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adu</title><author>Kilfoyle D</author><journal>N Z Med J</journal><year>2005</year><book /><volume>118</volume><number>0</number><pages>U1320</pages><co_aut>et al.</co_aut></literature><literature><id>2340</id><title>Quantitation of long-chain acylcarnitines by HPLC/fluorescence detection: application to plasma and tissue specimens from patie</title><author>Minkler PE</author><journal>Clin Chim Acta</journal><year>2005</year><book /><volume>352</volume><number>0</number><pages>81-92</pages><co_aut>et al.</co_aut></literature><literature><id>2341</id><title>Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations</title><author>Orngreen MC</author><journal>Ann Neurol</journal><year>2005</year><book /><volume>57</volume><number>1</number><pages>60-66</pages><co_aut>et al.</co_aut></literature><literature><id>2337</id><title>Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects</title><author>Bonnefont JP</author><journal>Mol Aspects Med</journal><year>2004</year><book /><volume>25</volume><number>5</number><pages>495-520</pages><co_aut>et al.</co_aut></literature><literature><id>1509</id><title>Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review</title><author>Sigauke E</author><journal>Lab Invest</journal><year>2003</year><book /><volume>83</volume><number>11</number><pages>1543-1554</pages><co_aut>et al.</co_aut></literature><literature><id>1709</id><title>Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients</title><author>Wieser T</author><journal>Neurology</journal><year>2003</year><book /><volume>60</volume><number>8</number><pages>1351-1352</pages><co_aut>et al.</co_aut></literature><literature><id>1710</id><title>A novel splice site mutation in neonatal carnitine palmitoyl transferase II deficiency</title><author>Smeets RJ</author><journal>J Hum Genet</journal><year>2003</year><book /><volume>48</volume><number>1</number><pages>8-13</pages><co_aut>et al.</co_aut></literature><literature><id>1266</id><title>Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry</title><author>Gempel K</author><journal>J Inherit Metab Dis</journal><year>2002</year><book /><volume>25</volume><number>1</number><pages>17-27</pages><co_aut>et al.</co_aut></literature><literature><id>1711</id><title>Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase II</title><author>Haap M</author><journal>J Clin Endocrinol Metab</journal><year>2002</year><book /><volume>87</volume><number>5</number><pages>2139-2143</pages><co_aut>et al.</co_aut></literature><literature><id>1712</id><title>Antenatal presentation of carnitine palmitoyltransferase II deficiency</title><author>Elpeleg ON</author><journal>Am J Med Genet</journal><year>2001</year><book /><volume>102</volume><number>2</number><pages>183-187</pages><co_aut>et al.</co_aut></literature><literature><id>1713</id><title>Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy f</title><author>Chace DH</author><journal>Clin Chem</journal><year>2001</year><book /><volume>47</volume><number>7</number><pages>1166-1182</pages><co_aut>et al.</co_aut></literature><literature><id>94</id><title>Mitochondrial fatty acid oxidation disorders</title><author>Roe CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1501-1533</pages><co_aut>Coates PM</co_aut></literature><literature><id>267</id><title>Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys</title><author>North KN</author><journal>J Pediatr</journal><year>1995</year><book /><volume>127</volume><number>3</number><pages>414-420</pages><co_aut>et al.</co_aut></literature><literature><id>430</id><title>Acylcarnitines in intermediary metabolism</title><author>Sewell AC</author><journal>Eur J Pediatr</journal><year>1995</year><book /><volume>154</volume><number>0</number><pages>871-877</pages><co_aut>B&#246;hles HJ</co_aut></literature><literature><id>1767</id><title>Molecular characterization of inherited carnitine palmitoyltransferase II deficiency</title><author>Taroni F</author><journal>Proc Natl Acad Sci U S A</journal><year>1992</year><book /><volume>89</volume><number>18</number><pages>8429-8433</pages><co_aut>et al.</co_aut></literature><literature><id>348</id><title>Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II</title><author>Hug G</author><journal>N Engl J Med</journal><year>1991</year><book /><volume>325</volume><number>0</number><pages>1862</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>